Journal for ImmunoTherapy of Cancer (Nov 2021)
Peripherally-driven myeloid NFkB and IFN/ISG responses predict malignancy risk, survival, and immunotherapy regime in ovarian cancer
- Antonia Carla Testa,
- Sabine Tejpar,
- Ignace Vergote,
- Valentina Chiappa,
- An Coosemans,
- Thaïs Baert,
- Chiara Landolfo,
- Wouter Froyman,
- Dirk Timmerman,
- Tom Bourne,
- Abhishek D Garg,
- Patrizia Agostinis,
- Louis Boon,
- Daniela Fischerova,
- Caroline Van Holsbeke,
- Jenny Sprooten,
- Ann Vankerckhoven,
- Isaure Vanmeerbeek,
- Daniel M Borras,
- Yani Berckmans,
- Roxanne Wouters,
- Raquel S Laureano,
- Dominique Schols
Affiliations
- Antonia Carla Testa
- Dipartimento Scienze della Salute della Donna e del Bambino, Fondazione Policlinico Universitario A. Gemelli, Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy
- Sabine Tejpar
- Laboratory for Molecular Digestive Oncology, Department of Oncology, KU Leuven, Leuven, Belgium
- Ignace Vergote
- Department of Oncology, Leuven Cancer Institute, Laboratory of Tumor Immunology and Immunotherapy, KU Leuven, Leuven, Belgium
- Valentina Chiappa
- National Cancer Institute of Milan, Milan, Italy
- An Coosemans
- Department of Oncology, Leuven Cancer Institute, Laboratory of Tumor Immunology and Immunotherapy, KU Leuven, Leuven, Belgium
- Thaïs Baert
- Department of Oncology, Leuven Cancer Institute, Laboratory of Tumor Immunology and Immunotherapy, KU Leuven, Leuven, Belgium
- Chiara Landolfo
- Department of Oncology, Leuven Cancer Institute, Laboratory of Tumor Immunology and Immunotherapy, KU Leuven, Leuven, Belgium
- Wouter Froyman
- Department of Development and Regeneration, KU Leuven, Leuven, Belgium
- Dirk Timmerman
- Department of Development and Regeneration, KU Leuven, Leuven, Belgium
- Tom Bourne
- Queen Charlotte`s and Chelsea Hospital, Imperial College, London, UK
- Abhishek D Garg
- Laboratory of Cell Stress & Immunity, Department of Cellular & Molecular Medicine, KU Leuven, Leuven, Belgium
- Patrizia Agostinis
- Department of Cellular and Molecular Medicine, Cell Death Research and Therapy Laboratory, KU Leuven, Belgium
- Louis Boon
- JJP Biologics, Warsaw, Poland
- Daniela Fischerova
- Charles University, Praha, Czech Republic
- Caroline Van Holsbeke
- Ziekenhuis Oost-Limburg, Genk, Belgium
- Jenny Sprooten
- Laboratory of Cell Stress & Immunity, Department of Cellular & Molecular Medicine, KU Leuven, Leuven, Belgium
- Ann Vankerckhoven
- Department of Oncology, Leuven Cancer Institute, Laboratory of Tumor Immunology and Immunotherapy, KU Leuven, Leuven, Belgium
- Isaure Vanmeerbeek
- Laboratory of Cell Stress & Immunity, Department of Cellular & Molecular Medicine, KU Leuven, Leuven, Belgium
- Daniel M Borras
- Laboratory of Cell Stress & Immunity, Department of Cellular & Molecular Medicine, KU Leuven, Leuven, Belgium
- Yani Berckmans
- Department of Oncology, Leuven Cancer Institute, Laboratory of Tumor Immunology and Immunotherapy, KU Leuven, Leuven, Belgium
- Roxanne Wouters
- Department of Oncology, Leuven Cancer Institute, Laboratory of Tumor Immunology and Immunotherapy, KU Leuven, Leuven, Belgium
- Raquel S Laureano
- Laboratory of Cell Stress & Immunity, Department of Cellular & Molecular Medicine, KU Leuven, Leuven, Belgium
- Dominique Schols
- Department of Microbiology, Immunology and Transplantation, Laboratory of Virology and Chemotherapy, Rega Institute, KU Leuven, Leuven, Belgium
- DOI
- https://doi.org/10.1136/jitc-2021-003609
- Journal volume & issue
-
Vol. 9,
no. 11
Abstract
No abstracts available.